Epizyme Announces Presentation at J.P. Morgan 35th Annual Healthcare Conference
Jan 03, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass., Jan. 03, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that Robert Bazemore, chief executive officer of Epizyme,...
Global Radiopharmaceuticals Technologies and Markets Report: 2014-2016 & 2016-2021
Jan 03, 2017 11:26 am UTC| Business
Dublin, Jan. 03, 2017 -- Research and Markets has announced the addition of the "Radiopharmaceuticals: Technologies and Global Markets" report to their offering. The global market...
Jan 03, 2017 11:20 am UTC| Business
Dublin, Jan. 03, 2017 -- Research and Markets has announced the addition of the "Commercial Flooring: North American Markets" report to their offering. The North American...
Lake Norman Marina and Dealer Spike: A Partnership Founded in Excellence
Jan 03, 2017 11:17 am UTC| Business
Portland, OR, Jan. 03, 2017 -- Picture this - A beautiful lake surrounded by trees that turn all shades of green, red, and yellow with the changing seasons. A marina hosting premium quality Cobalt and Bennington boats,...
Natus Completes Acquisition of GN Otometrics Business
Jan 03, 2017 11:00 am UTC| Business
PLEASANTON, Calif., Jan. 03, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it has completed the acquisition of GN Otometrics from GN Store Nord A/S (GN.CO) that was announced on September 26,...
AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference
Jan 03, 2017 11:00 am UTC| Business
ALBANY, N.Y., Jan. 03, 2017 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today...
Cesca Therapeutics to Present at the 9th Annual Biotech Showcase
Jan 03, 2017 11:00 am UTC| Business
RANCHO CORDOVA, Calif., Jan. 03, 2017 -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapeutics, today announced that it is scheduled...